Global pharma major Lupin Limited (Lupin) announced the appointment of Christoph Funke to the newly-created position of Chief Technical Operations Officer. With over 30 years of global pharmaceutical manufacturing, supply chain, and technical operations experience, Christoph brings a wealth of expertise to Lupin. He will be based in Mumbai and will oversee Lupin’s Technical Operations…
TiE Silicon Valley, the founding chapter of TiE, announced that Jagdeep Singh Bachher, the University of California’s chief investment officer, will join the TiE Silicon Valley Board. Bachher is responsible for managing more than $150 billion across the UC endowment, pension, retirement savings, working capital, and insurance assets, a statement said. “Innovation and entrepreneurship are critical to solving the…
Global pharmaceutical major Lupin Limited (Lupin) announced signing of an agreement to acquire all rights to two inhalation medicines, Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, from Sunovion Pharmaceuticals Inc. (Sunovion) for a purchase price of $75 million. The acquisition of these two brands expands Lupin’s portfolio of inhalation products…
Global pharma major Lupin Limited (Lupin) announced the appointment of Dr. Shahin Fesharaki as Global Chief Scientific Officer. Dr. Fesharaki will be responsible for Lupin’s global research and development efforts across branded, generics and specialty products, a statement said. Commenting on the appointment, Vinita Gupta, CEO and Nilesh Gupta, MD, Lupin said, “We are very…
Global pharma major Lupin Limited (Lupin) announced the appointment of Diana Amador-Toro as Senior Vice President, Global Compliance. Diana will be responsible for leading Lupin’s Global Compliance function including Training, Internal Audit, and Investigations. She will be based in Lupin’s Somerset office in New Jersey, USA. Diana is a senior leader with more than 38…
Global pharma major, Lupin Limited (Lupin) announced changes to its executive team with Dr. Fabrice Egros assuming responsibilities for Global Corporate Development as President, Corporate Development and Growth Markets. Dr. Egros takes over the Corporate Development role from Alan Butcher departing from the Company on February 28, 2022. Dr. Egros will lead the development and…
Lupin board of directors has approved the appointment of Vinita Gupta as Chief Executive Officer and Nilesh D. Gupta as Managing Director from September 2013. Vinita and Nilesh are children of Dr. Desh Bandhu Gupta, Lupin’s Founder and Chairman. Kamal K. Sharma, present the company’s Managing Director would move up as Vice-Chairman. Vinita Gupta, has…